Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer

Recruiting

Phase 2

mFOLFOX & RadiationTotal Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer

Sponsor:

Virginia Commonwealth University

Code:

NCT04643366

Conditions

Rectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Chemotherapy

Radiation Therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Virginia Commonwealth University on 2025-02-21.